Isoliquiritigenin: a potential drug candidate for the management of erectile dysfunction.

Queen SaikiaKamal AdhikariAiry SanjeevAjit HazarikaKishore Sarma

Published in: The Journal of pharmacy and pharmacology (2024)

The results showed that ISL is equally potent as SDF in terms of binding affinity, specific pharmacological properties, and modulating sexual behavior.

Keyphrases

signaling pathway
anti inflammatory
dna binding
adverse drug
capillary electrophoresis